Cancer Liaison Program

The staff of the Cancer Liaison Program, located in FDA's Office of Special Health Issues, work with FDA's oncology medical staff to bring the patient advocate's perspective into the review of new drugs to treat cancer. The staff also meets with organized patient advocacy groups to listen to their concerns about drug development and to assist them in understanding the FDA drug regulatory process. Calls from cancer patients and their loved ones are routinely answered by the staff to help callers with questions about cancer clinical trials and/or cancer drug development.